Yıl: 2013 Cilt: 9 Sayı: 2 Sayfa Aralığı: 64 - 68 Metin Dili: Türkçe İndeks Tarihi: 29-07-2022

A preliminary study: Comparative proteomic profiling of breast cancer tissue and metastatic axillary lymph node

Öz:
Amaç: Meme kanseri kadınlarda en sık görülen malignitelerden biri olmaya devam etmektedir. Aksiller lenf nodu (ALN) tutulumu meme kanserinde te- davi yöntemlerine karar verme aşamasında kullanışlı bir klinik parametredir. ALN diseksiyonu üst ekstremitelerde lenf ödem ve diğer morbiditelere neden olabilse de ALN’nda metastaz olması meme kanseri hastalarında sağ kalımı öngörmede en önemli prognostik faktördür. Primer meme kanserinin tümör ile ilişkili proteinlerin ekspresyonunun değerlendirilmesi ile ALN’nda metastaz öngörülmesi açısından primer tümör ile ilgili bilgimiz olduğu için potansiyel olarak yararlı bir yaklaşımdır. Yöntem ve Gereçler: Proteomik analiz meme kanseri araştırmalarında kullanı- lan bir araçtır. Bu ön çalışmada biz primer tümör ve meme kanserinin ALN’na metastazı arasında protein ekspresyon içeriğindeki değişikleri araştırmak iste- dik. Bu amaçla iyi ve oldukça güvenilir bir proteomik yöntemi olan iki boyutlu poliakrilamid jel elektroforez (2D-PAGE) ve spot görüntüleme analizi kullanıldı. Bulgular: Bizim görüntüleme analizlerimizin ışığı altında proteomikin primer meme kanseri ve ALN dokusunda protein profilini tanımlamak suretiyle ALN metastazının öngörülebileceğini hipotezledik. 2DE analizinden elde edilen sonuçlar, primer meme kanseri ve ALN dokusu arasında 24 protein spotunun varlığını gösterdi. Sonuç: Bu aday proteinler lenfatik dokuya kanser yayılımının arkasındaki ge- rekçeleri ortaya koyabilir ve bu hayatı tehdit eden hastalığın erken tanısına yardımcı olabilir.
Anahtar Kelime:

Konular: Onkoloji

Bir ön çalışma: meme kanseri dokusunun ve aksiller metastatik lenf nodunun proteomik profillenmesi

Öz:
Objective: Breast cancer remains one of the most common malignancies affect- ing women. In breast cancer, axillary lymph node (ALN) involvement is a useful clinical parameter for decision-making. Although ALN dissection is associated with upper extremity lymphoedema and other morbidities, the presence of ALN metastasis is the most important prognostic factor predicting breast can- cer patient survival. The prediction of ALN metastasis by evaluating expression of tumor-related proteins of primary breast cancer is potentially a promising approach because the primary tumor is readily assessed. Materials and Methods: Proteomic analysis has become an effective tool in breast cancer research. In this preliminary study, we aimed to examine the changes in protein expression patterns between the primary tumor and its axillary lymph node (ALN) metastasis of breast cancer. A robust and highly re- liable proteomics approach that is based on two-dimensional polyacrylamide gel electrophoresis (2D-PAGE) and spot image analysis was used. Results: In the light of our image analysis, we hypothesized that proteomics could predict ALN metastasis by pinpointing the alterations in protein profiles of primary breast cancer and axillary lymph node tissues. Results obtained from analysis of 2DE images revealed the presence of 24 conserved protein spots between primary breast cancer and its axiliary lymph node tissue. Conclusion: These candidate proteins may provide clues to the molecular mechanism of cancer spread into the lymphatic tissue and may allow early detection of this devastating disease.
Anahtar Kelime:

Konular: Onkoloji
Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • Kaynaklar 1. Ozmen V. Breast cancer in the world and Turkey. Meme Sağlığı Der- gisi 2008; 4: 7-12.
  • 2. Cunnick GH, Jiang WG, Douglas-Jones T, Watkins G, Gomez KF, Mor- gan MJ, et al. Lymphangiogenesis and lymph node metastasis in breast cancer. Mol Cancer 2008; 6: 23. (PMID: 18325094)
  • 3. Kohn EC, Liotta LA. Molecular Insights into Cancer Invasion: Strate- gies for Prevention and Intervention. Cancer Res 1995; 55: 1856-62. (PMID: 7728753)
  • 4. Alitalo A, Detmar M. Interaction of tumor cells and lymphatic ves- sels in cancer progression. Oncogene 2012; 31: 4499-508. (PMID: 22179834)
  • 5. Nemoto T, Natarajan N, Bedwani R, Vana J, Murphy GP. Breast cancer in the medial half. Results of 1978 National Survey of the American Colle- ge of Surgeons. Cancer 1983; 51: 1333-8. (PMID: 6825053) [CrossRef]
  • 6. Rakha EA, Morgan D, Macmillan D. The prognostic significance of early stage lymph node positivity in operable invasive breast car- cinoma: number or stage. J Clin Pathol 2012; 65: 624-30. (PMID: 22523340) [CrossRef]
  • 7. Dent DM. Axillary lymphadenectomy for breast cancer. Paradigm shifts and pragmatic surgeons. Arch Surg 1996; 131: 1125-7. (PMID: 8911250) [CrossRef]
  • 8. Mirza A N, Mirza NQ, Vlastos G, Singletary SE. Prognostic factors in node-negative breast cancer: a review of studies with sample size more than 200 and follow-up more than 5 years. Annals Surg 2002; 235: 10-26. (PMID: 11753038) [CrossRef]
  • 9. Rack B, Janni W, Gerber B, Strobl B, Schindlbeck C, Klanner E, et al. Patients with recurrent breast cancer: does the primary axillary lym- ph node status predict more aggressive tumor progression? Breast Cancer Res Treat 2003; 82: 83-92. (PMID: 14692652) [CrossRef]
  • 10. Woodward WA, Vinh-Hung V, Ueno NT, Cheng YC, Royce M, Tai P, et al. Prognostic value of nodal ratios in node-positive breast cancer. J Clin Oncol 2006; 24: 2910-6. (PMID: 16782931) [CrossRef]
  • 11. Rosen PR, Groshen S, Saigo P E, Kinne DW, Hellman S. A long-term follow-up study of survival in stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma. J Clin Oncol 1989; 7: 355-66. (PMID: 2918331)
  • 12. Hellman S. Karnofsky Memorial Lecture. Natural history of small bre- ast cancers. J Clin Oncol 1994; 12: 2229-34. (PMID: 7931493)
  • 13. Weigelt B, Wessels LF, Bosma AJ, Glas AM, Nuyten DS, He YD, et al. No common denominator for breast cancer lymph node metastasis. Br. J. cancer 2005; 93: 924–32. (PMID: 16189523) [CrossRef]
  • 14. Stacker SA, Achen MG, Jussila L, Baldwin ME, Alitalo K. Lymphan- giogenesis and cancer metastasis. Nat Rev Cancer 2002; 2: 573-83. (PMID: 12154350) [CrossRef]
  • 15. Feng Y, Sun B, Li X, Zhang L, Niu Y, Xiao C, et al. Differentially expressed genes between primary cancer and paired lymph node metastases predict clinical outcome of node-positive breast cancer patients. Bre- ast Cancer Res Treat 2007; 103: 319-29. (PMID: 17123152) [CrossRef]
  • 16. Suzuki M, Tarin D. Gene expression profiling of human lymph node metastases and matched primary breast carcinomas : clinical impli- cations. Mol Oncol 2007; 1:172-80. (PMID: 19383293) [CrossRef]
  • 17. Vecchi M, Confalonieri S, Nuciforo P, Viganò MA, Capra M, Bianchi M, et al. Breast cancer metastases aremolecularly distinct from their primary tumors. Oncogene 2008; 27: 2148-58. (PMID: 17952122) [CrossRef]
  • 18. Li J, Gromov P, Gromova I, Moreira JM, Timmermans-Wielenga V, Rank F, et al. Omics-based profiling of carcinoma of the breast and matched regional lymph node metastasis. Proteomics 2008; 8: 5038- 52. (PMID: 19003862) [CrossRef]
  • 19. Daidone MG, Silvestrini R, Valentinis B, Persici P, Mezzanotte G, Squ- icciarini P, et al. Proliferative activity of primary breast cancer and of synchronous lymph node metastases evaluated by [3H]-thymidine labelling index. Cell Tissue Kinetics 1990; 23: 401-8. (PMID: 2245439)
  • 20. Goodson WH, Ljung BM, Moore DH, Mayall B, Waldman FM, Chew K, et al. Tumor labeling indices of primary breast cancers and their regional lymph node metastases. Cancer 1993; 71: 3914-9. (PMID: 8508357) [CrossRef]
  • 21. Lähdesmäki H, Hao X, Sun B, Hu L, Yli-Harja O, Shmulevich I, et al. Distinguishing key biological pathways between primary breast cancers and their lymph node metastases by gene function-based clustering analysis. Int J Oncol 2004; 24: 1589-96. (PMID: 15138604)
  • 22. Nishizaki T, DeVries S, Chew K, Goodson WH 3rd, Ljung BM, Thor A, et al. Genetic alterations in primary breast cancers and their metastases: direct comparison using modified comparative genomic hybridization. Genes Chromosomes Cancer 1997; 19: 267-72. (PMID: 9258662) [CrossRef]
  • 23. Lee HH, Lim CA, Cheong YT, Singh M, Gam LH. Comparison of Protein Expression Profiles of Different Stages of Lymph Nodes Metastasis in Bre- ast Cancer . Int J Biol Sci 2012; 8: 353-62. (PMID: 22393307) [CrossRef]
APA Akpınar G, Şimşek T, KASAP M, CANTÜRK N (2013). A preliminary study: Comparative proteomic profiling of breast cancer tissue and metastatic axillary lymph node. , 64 - 68.
Chicago Akpınar Gürler,Şimşek Turgay,KASAP Murat,CANTÜRK Nuh Zafer A preliminary study: Comparative proteomic profiling of breast cancer tissue and metastatic axillary lymph node. (2013): 64 - 68.
MLA Akpınar Gürler,Şimşek Turgay,KASAP Murat,CANTÜRK Nuh Zafer A preliminary study: Comparative proteomic profiling of breast cancer tissue and metastatic axillary lymph node. , 2013, ss.64 - 68.
AMA Akpınar G,Şimşek T,KASAP M,CANTÜRK N A preliminary study: Comparative proteomic profiling of breast cancer tissue and metastatic axillary lymph node. . 2013; 64 - 68.
Vancouver Akpınar G,Şimşek T,KASAP M,CANTÜRK N A preliminary study: Comparative proteomic profiling of breast cancer tissue and metastatic axillary lymph node. . 2013; 64 - 68.
IEEE Akpınar G,Şimşek T,KASAP M,CANTÜRK N "A preliminary study: Comparative proteomic profiling of breast cancer tissue and metastatic axillary lymph node." , ss.64 - 68, 2013.
ISNAD Akpınar, Gürler vd. "A preliminary study: Comparative proteomic profiling of breast cancer tissue and metastatic axillary lymph node". (2013), 64-68.
APA Akpınar G, Şimşek T, KASAP M, CANTÜRK N (2013). A preliminary study: Comparative proteomic profiling of breast cancer tissue and metastatic axillary lymph node. Meme Sağlığı Dergisi, 9(2), 64 - 68.
Chicago Akpınar Gürler,Şimşek Turgay,KASAP Murat,CANTÜRK Nuh Zafer A preliminary study: Comparative proteomic profiling of breast cancer tissue and metastatic axillary lymph node. Meme Sağlığı Dergisi 9, no.2 (2013): 64 - 68.
MLA Akpınar Gürler,Şimşek Turgay,KASAP Murat,CANTÜRK Nuh Zafer A preliminary study: Comparative proteomic profiling of breast cancer tissue and metastatic axillary lymph node. Meme Sağlığı Dergisi, vol.9, no.2, 2013, ss.64 - 68.
AMA Akpınar G,Şimşek T,KASAP M,CANTÜRK N A preliminary study: Comparative proteomic profiling of breast cancer tissue and metastatic axillary lymph node. Meme Sağlığı Dergisi. 2013; 9(2): 64 - 68.
Vancouver Akpınar G,Şimşek T,KASAP M,CANTÜRK N A preliminary study: Comparative proteomic profiling of breast cancer tissue and metastatic axillary lymph node. Meme Sağlığı Dergisi. 2013; 9(2): 64 - 68.
IEEE Akpınar G,Şimşek T,KASAP M,CANTÜRK N "A preliminary study: Comparative proteomic profiling of breast cancer tissue and metastatic axillary lymph node." Meme Sağlığı Dergisi, 9, ss.64 - 68, 2013.
ISNAD Akpınar, Gürler vd. "A preliminary study: Comparative proteomic profiling of breast cancer tissue and metastatic axillary lymph node". Meme Sağlığı Dergisi 9/2 (2013), 64-68.